Source: Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Wei-jie Guan, Yan Huang, Chun-lan Chen, Rong-chang Chen, Nan-shan Zhong. Macrolides, mucoactive drugs and adherence for the management of bronchiectasis. Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory therapies in bronchiectasis Source: Eur Respir Mon 2011; 52: 223-238 Year: 2011 Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011 Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018 Year: 2019 Macrolides as anti-inflammatory agents in CAP Source: Eur Respir Monogr 2014; 63: 243-255 Year: 2014 Long-term macrolide therapy in chronic inflammatory airway diseases Source: Eur Respir J 2009; 33: 171-181 Year: 2009 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Inhaled antimicrobials Source: ERS webinar 2020: Inhaled antimicrobials Year: 2020 Antibiotic treatment and prevention of exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 96-106 Year: 2013 Non-steroidal anti-inflammatory drug use and clinical outcomes of community-acquired pneumonia Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis Source: ERJ Open Res, 8 (1) 00786-2020; 10.1183/23120541.00786-2020 Year: 2022 Use of antibiotics, antioxidants, mucolytics and vaccines in the therapy of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=296 Year: 2006 Side-effect in the treatment of pulmonary tuberculosis by first-line drugs Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Prevention and treatment of exacerbations of non-CF bronchiectasis Source: Eur Respir Monogr 2013; 60: 127-136 Year: 2013 Do empiric antibiotics delay appropriate antituberculosis medication in patients with active pulmonary tuberculosis? Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Mucolytics and anti-inflammatory lung treatments Source: ERS course 2015 Year: 2015 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 Azithromycin in the anti-inflammatory treatment of children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004 Inhaled therapy in cystic fibrosis: agents, devices and regimens Source: Breathe 2015; 11:110-118 Year: 2015